Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.
about
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgarisPropionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatmentTreatment effects of lysozyme-shelled microbubbles and ultrasound in inflammatory skin disease.Treating acne with antibiotic-resistant bacterial colonization.Epidemiology of acne vulgaris.Immunotherapy for acne vulgaris: current status and future directions.Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgarisStaphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.Emerging drugs for acne.Acne-associated syndromes: models for better understanding of acne pathogenesis.What is new in the pathophysiology of acne, an overview.Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway.Anti-acne drugs in phase 1 and 2 clinical trials.Pro-inflammatory effects of different MWCNTs dispersions in p16(INK4A)-deficient telomerase-expressing human keratinocytes but not in human SV-40 immortalized sebocytes.Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.
P2860
Q24645431-9F3FBF72-CE5B-4047-9945-9A5A1AEB9B34Q28741201-C4799FC2-DE65-4525-A1C0-0DA7E1A6795CQ30365103-1BBEEA81-909E-49F8-9CD8-FE4140FCD3F0Q34167188-39FD6BB8-3EF9-4C1C-8DFF-EF160832139BQ34315508-BC0A585F-4EBD-4311-B6C9-CBA5D9A58463Q34369858-1AAC9D8E-B64F-4CCF-AA57-6110DE798E9DQ36072897-F816B16A-708D-45D5-810B-8D8F74A699A8Q37463929-A0D2E1F9-2427-44C8-BD51-85845D5899B3Q37601477-E90C6CF3-1F9F-4431-AD5D-F3A5DFEA96C6Q37825558-B5DE955F-BAE2-4C85-9DFB-2A51C336689AQ38642921-98D9D6FA-73B2-4239-B110-4DAB10F4DA32Q39333793-29CB4AA1-B48E-4073-8117-72A975AF3E8AQ39382177-6DBBDC18-FC35-4F5E-887F-F652CFA110CFQ39586053-5E774681-FD31-44B4-AB42-AB2CA86BDE2BQ41126889-7B3C8F0C-EF6F-414B-A626-BD31D8D96476
P2860
Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@ast
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@en
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@nl
type
label
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@ast
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@en
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@nl
prefLabel
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@ast
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@en
Antibodies elicited by inactiv ...... to therapy for acne vulgaris.
@nl
P2093
P2860
P356
P1476
Antibodies elicited by inactiv ...... e to therapy for acne vulgaris
@en
P2093
Cheng-Po Huang
Christos C Zoubouis
Chun-Ming Huang
Teruaki Nakatsuji
Yu-Tsueng Liu
P2860
P2888
P304
P356
10.1038/JID.2008.117
P407
P577
2008-05-08T00:00:00Z
P5875
P6179
1035676626